Microbiology testing

Ended Awarded Last action

Contract number
W91YTZ20F0276
Awardee
Awarding agency
Obligated
$554,676

Award facts

Opportunity
  • W91YTZ20Q0254 Solicitation number
Contract value 100% obligated
$554,676.21 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Fort Belvoir, VA 22060, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00014 · KRJ FY24 DE-OB micro reagent testing-bragg -$38,457
Funding Only Action P00013 · VGM FY25 funding microbiology testing (WAMC) $135,295
Funding Only Action P00012 · FY24 DE-obligation Q3 W91YTZ20F0276 BD -$30,000
Exercise an Option P00011 · FY25 option W91YTZ20F0276 OY4 $0
Funding Only Action P00010 · MOD - microbiology testing - FY24 funding $135,295
Exercise an Option P00009 · MOD FY24OY3 $0
Funding Only Action P00008 -$144,202
Funding Only Action P00007 · MOD fund FY23 $182,248
Terminate for Convenience P00006 · MOD deob FY22 microbiology testing -$50,000
Exercise an Option P00005 · MOD- option year 2 FY23 SAF BD bacteria reagents $0
Funding Only Action P00004 · MOD fund OY1 FY22 funding BD bacterial reagents $182,248
Exercise an Option P00003 $0
Other Administrative Action P00002 $0
Funding Only Action P00001 $182,248
Original award $0
Show all 15

About this award

This delivery order, awarded to Becton, Dickinson and Company's Infectious Disease Systems division on October 1, 2020, provides microbiology testing reagents and related supplies to support laboratory operations at Fort Belvoir, Virginia. Valued at $554,676.21 on a firm fixed-price basis, the delivery order falls under the GSA Schedule for Critical Analyzers, Laboratory (FSS-66-III) and is funded by the Defense Health Agency. The contract carries an ultimate completion date of September 30, 2025, and was awarded without a set-aside designation, reflecting BD's competitive position as an established large business supplier of advanced diagnostic equipment and laboratory reagents to federal healthcare institutions.

The Defense Health Agency selected BD based on the company's extensive experience providing microbiology identification systems, diagnostic reagents, and laboratory consumables to military medical treatment facilities. BD's Infectious Disease Systems division specializes in blood culture analyzers, microbiology testing equipment, and related reagents—capabilities well-aligned with the Department of Defense's laboratory diagnostic needs across its healthcare delivery network. This delivery order represents one of numerous awards BD has received from the Defense Health Agency and broader Department of Defense entities for specialized diagnostic testing supplies and services supporting military medical operations.

Quick answers

Who was awarded contract W91YTZ20F0276?

W91YTZ20F0276 was awarded to Becton, Dickinson And Company by Medical Command (Department of the Army) on October 1, 2020.

How much is contract W91YTZ20F0276 worth?

The government has obligated $554,676 on W91YTZ20F0276.

Which agency awarded contract W91YTZ20F0276?

Medical Command (Department of the Army) awarded W91YTZ20F0276, with funding from Defense Health Agency (Department of Defense).

Is contract W91YTZ20F0276 an order under another contract?

Yes. W91YTZ20F0276 is a delivery order under V797D40095, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract W91YTZ20F0276 competed?

The extent of competition for W91YTZ20F0276 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award